3 Billion Inc.Z5.D483billion provides genetic testing for patients with rare genetic diseases. 3billion is revolutionizing existing methods and procedures with our breakthrough technology helping to diagnose quicker with a higher diagnosis rate.
3billion is the fastest-growing company in the field of genetic testing for rare diseases.
3billion recorded 3.7x revenue growth in 2023 compared to 2022.
We are expanding diagnostic cooperation with global pharmaceutical companies and improving patients' lives with rare diseases more rapidly.
